Geoffrey B Pardo has bought stock on 3 days since Jul 2021
Director at SpyGlass Pharma, Inc., and 2 other companies
SEC CIK 0001753143 · Filings on SEC.gov ↗
Geoffrey B Pardo's record
3 months after each buy, from the first price a copier could get.
2 buys have 3 months of prices so far. A record shows here at 3.
Companies
Every filing
3 filings since Jul 2021, newest first
About Geoffrey B Pardo
Geoffrey B. Pardo is a seasoned medtech investor and executive serving as an Independent Director at Shoulder Innovations, Inc. (SI) since 2023.( He recently purchased 100,000 shares of Shoulder Innovations at $15 per share, investing approximately $1.5 million, signaling strong confidence in the company.(
Pardo joined Gilde Healthcare in 2011 as a Partner (now General Partner) in their Boston/Cambridge office, leading investments in North America including Inari Medical (NASDAQ: NARI), Axonics (NASDAQ: AXNX), CVRx, and Shoulder Innovations.( Previously, he was President & CEO of Facet Solutions, a spinal implant company treating lumbar spinal stenosis, until its sale to Globus Medical in 2011; Partner at Spray Venture Partners, leading deals like Interlace Medical (sold to Hologic); and an Associate at Cardinal Partners.( He began his career as a product manager at Synthes USA and holds a BA with honors in History from Brown University and an MBA from The Wharton School.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.